The 5-HT2A/1A Agonist Psilocybin Disrupts Modal Object Completion Associated with Visual Hallucinations March 1, 2011
Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs February 15, 2011
Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens January 20, 2011
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer January 3, 2011
Is Ecstasy an “Empathogen”? Effects of ±3,4-Methylenedioxymethamphetamine on Prosocial Feelings and Identification of Emotional States in Others December 15, 2010
Lack of effect of sublingual salvinorin A, a naturally occurring kappa opioid, in humans: a placebo-controlled trial December 8, 2010
